FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Craig Miller

Research Profile

Disorders

Prostatic Neoplasms

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Robert W Veltri; Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Alan W Partin
Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy.
Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Elizabeth Humphreys; Alan W Partin; Robert W Veltri
DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.
Robert W Veltri; Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Elizabeth Humphreys; Alan W Partin
Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Craig Miller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Robert W Veltri; Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Alan W Partin
Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy.
The Prostate 2010;70(12):1333-9.
2009: Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Elizabeth Humphreys; Alan W Partin; Robert W Veltri
DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.
Urology 2009;73(5):1092-7.
2008: Robert W Veltri; Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Elizabeth Humphreys; Alan W Partin
Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.
The Prostate 2008;68(16):1806-15.
2008: Sumit Isharwal; M Craig Miller; Cameron Marlow; Danil V Makarov; Alan W Partin; Robert W Veltri
p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.
The Prostate 2008;68(10):1097-104.
2008: Danil V Makarov; Cameron Marlow; Jonathan I Epstein; M Craig Miller; Patricia Landis; Alan W Partin; H Ballentine Carter; Robert W Veltri
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent.
The Prostate 2008;68(2):183-9.
2008: Robert W Veltri; M Craig Miller; Sumit Isharwal; Cameron Marlow; Danil V Makarov; Alan W Partin
Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(1):102-10.
2007: Jana Müller; M Craig Miller; Alex Toftgaard Nielsen; Gary K Schoolnik; Alfred M Spormann
vpsA- and luxO-independent biofilms of Vibrio cholerae.
FEMS microbiology letters 2007;275(2):199-206.
2007: Robert W Veltri; Cameron Marlow; Masood A Khan; M Craig Miller; Jonathan I Epstein; Alan W Partin
Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis.
The Prostate 2007;67(11):1202-10.
2007: Daniel P Keymer; M Craig Miller; Gary K Schoolnik; Alexandria B Boehm
Genomic and phenotypic diversity of coastal Vibrio cholerae strains is linked to environmental factors.
Applied and environmental microbiology 2007;73(11):3705-14.
2007: M Craig Miller; Daniel P Keymer; Abigail Avelar; Alexandria B Boehm; Gary K Schoolnik
Detection and transformation of genome segments that differ within a coastal population of Vibrio cholerae strains.
Applied and environmental microbiology 2007;73(11):3695-704.
2006: Robert W Veltri; Masood A Khan; Cameron Marlow; M Craig Miller; Stephen D Mikolajczyk; Munekado Kojima; Alan W Partin; Leonard S Marks
Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancer.
Urology 2006;68(4):898-904.
2006: Alex Toftgaard Nielsen; Nadia A Dolganov; Glen Otto; M Craig Miller; Cheng Yen Wu; Gary K Schoolnik
RpoS controls the Vibrio cholerae mucosal escape response.
PLoS pathogens 2006;2(10):e109.
2004: Robert W Veltri; Masood A Khan; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Patrick C Walsh; Alan W Partin
Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3465-73.
2004: Robert W Veltri; J Park; M Craig Miller; L Marks; M Kojima; C van Rootselaar; Masood A Khan; Alan W Partin
Stromal-epithelial measurements of prostate cancer in native Japanese and Japanese-American men.
Prostate cancer and prostatic diseases 2004;7(3):232-7.
2003: Masood A Khan; Patrick C Walsh; M Craig Miller; Wesley D Bales; Jonathan I Epstein; Leslie A Mangold; Alan W Partin; Robert W Veltri
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.
Cancer 2003;98(12):2583-91.
2003: Masood A Khan; H Ballentine Carter; Jonathan I Epstein; M Craig Miller; Patricia Landis; Patrick C Walsh; Alan W Partin; Robert W Veltri
Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?
The Journal of urology 2003;170(6 Pt 1):2274-8.
2003: Alexander Haese; Manisha Chaudhari; M Craig Miller; Jonathan I Epstein; Hartwig Huland; Jüri Palisaar; Markus Graefen; Peter Hammerer; Edward C Poole; Gerard J O'Dowd; Alan W Partin; Robert W Veltri
Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.
Cancer 2003;97(4):969-78.
2003: Joseph C Presti; Gerard J O'Dowd; M Craig Miller; Rubina Mattu; Robert W Veltri
Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study.
The Journal of urology 2003;169(1):125-9.
2002: Robert W Veltri; Leonard S Marks; M Craig Miller; Wesley D Bales; John Fan; Maria Luz Macairan; Jonathan I Epstein; Alan W Partin
Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism.
Urology 2002;60(4):617-22.
2002: Robert W Veltri; M Craig Miller; Gerard J O'Dowd; Alan W Partin
Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer.
Urology 2002;60(4 Suppl 1):47-52.
2002: Robert W Veltri; Manisha Chaudhari; M Craig Miller; Edward C Poole; Gerard J O'Dowd; Alan W Partin
Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stage.
Clinical chemistry 2002;48(10):1828-34.
2002: Robert W Veltri; M Craig Miller; Leslie A Mangold; Gerard J O'Dowd; Jonathan I Epstein; Alan W Partin
Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
The Journal of urology 2002;168(1):100-4.
2001: Robert W Veltri; M Craig Miller; Alan W Partin; Edward C Poole; Gerard J O'Dowd
Prediction of prostate carcinoma stage by quantitative biopsy pathology.
Cancer 2001;91(12):2322-8.
2001: M Craig Miller; Gerard J O'Dowd; Alan W Partin; Robert W Veltri
Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics.
Urology 2001;57(6):1105-11.
2000: Gerard J O'Dowd; M Craig Miller; roberto e orozco; Robert W Veltri
Analysis of repeated biopsy results within 1 year after a noncancer diagnosis.
Urology 2000;55(4):553-9.
1999: Steven R Potter; M Craig Miller; Leslie A Mangold; K A Jones; Jonathan I Epstein; Robert W Veltri; Alan W Partin
Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy.
Urology 1999;54(5):791-5.
1998: Robert W Veltri; Gerard J O'Dowd; roberto e orozco; M Craig Miller
The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the preoperative prediction of prostate cancer staging and prognosis.
Seminars in urologic oncology 1998;16(3):106-17.
1998: E M Wojcik; M Craig Miller; Gerard J O'Dowd; Robert W Veltri
Value of computer-assisted quantitative nuclear grading in differentiation of normal urothelial cells from low and high grade transitional cell carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1998;20(1):69-76.
1998: roberto e orozco; Gerard J O'Dowd; B Kunnel; M Craig Miller; Robert W Veltri
Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.
Urology 1998;51(2):186-95.
1997: E M Wojcik; M Craig Miller; B C Wright; Robert W Veltri; Gerard J O'Dowd
Comparative analysis of DNA content in polyomavirus-infected urothelial cells, urothelial dysplasia and high grade transitional cell carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1997;19(5):430-6.
1997: Gerard J O'Dowd; Robert W Veltri; roberto e orozco; M Craig Miller; J E Oesterling
Update on the appropriate staging evaluation for newly diagnosed prostate cancer.
The Journal of urology 1997;158(3 Pt 1):687-98.
1996: R A Badalament; M Craig Miller; P A Peller; Donn C Young; DK Bahn; P Kochie; Gerard J O'Dowd; Robert W Veltri
An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level.
The Journal of urology 1996;156(4):1375-80.